Form 10-Q · Quarterly report
Intuitive Surgical 10-Q, filed Jul 21, 2026
- Filed
- CIK
- 0001035267
- Accession no.
- 0001035267-26-000058
Summary
Intuitive Surgical reported on the commercialization and regulatory progress of its da Vinci and Ion surgical systems, noting that the da Vinci 5 system has secured approvals in several international markets and reached an installed base of 1,710 units. Additionally, the company outlined recent developments regarding U.S. trade tariffs, which are currently subject to appeals in the U.S. Court of Appeals for the Federal Circuit.
Written by an AI model from the filing text. It can be incomplete or wrong; the filing on SEC.gov is the record.
From the filing
ITEM 2. MANAGEMENT’S DISCUSSION Overview As part of our mission, we believe that minimally invasive care is life-enhancing care. Since our founding over 30 years ago, we have been delivering on this mission by combining innovative technology with clinical expertise to advance minimally invasive care. We do so by providing a comprehensive ecosystem that includes robotic-assisted systems, instruments and accessories, customer learning, and support services all connected by a digital portfolio that enables actionable insights across the care continuum. …
An excerpt of the text as filed with the SEC, cut for length.
Readster writes AI-generated summaries of public filings for research purposes only. Summaries can be incomplete or wrong — check the original filing on SEC.gov before relying on it. Nothing here is investment, legal or medical advice.